✦ LIBER ✦

Therapeutic efficacy of humanized recombinant anti–interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis

✍ Scribed by Shumpei Yokota; Takako Miyamae; Tomoyuki Imagawa; Naomi Iwata; Shigeki Katakura; Masaaki Mori; Patricia Woo; Norihiro Nishimoto; Kazuyuki Yoshizaki; Tadamitsu Kishimoto

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 111 KB
Volume: 52
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.20944

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Successful use of a humanized anti–inter

Successful use of a humanized anti–interleukin-6 receptor antibody, tocilizumab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis

✍ Yasuaki Okuda; Kiyoshi Takasugi 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 329 KB 👁 1 views

## Abstract We report an excellent clinical response to treatment with a humanized anti–interleukin‐6 receptor antibody, tocilizumab, in a patient with progressive amyloid A (AA) amyloidosis complicating very active juvenile idiopathic arthritis. Treatment with tocilizumab immediately normalized th

Therapeutic benefit of blocking interleu

Therapeutic benefit of blocking interleukin-6 activity with an anti–interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: A randomized, double-blind, placebo-controlled, dose-escalation trial

✍ E. H. S. Choy; D. A. Isenberg; T. Garrood; S. Farrow; Y. Ioannou; H. Bird; N. Ch 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB 👁 1 views